PATENT CLAIM ANALYSIS

Application Number: 16323529
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-05
Patent Classification: ["514", "253090"]

Abstract:
The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.

Claim (Index 1):
A compound of formula (I) wherein R 1  is hydrogen, C 1-6 alkyl or phenyl, wherein the C 1-6 alkyl is optionally substituted by \u2014CF 3  and the phenyl is optionally substituted by one or two substituents independently selected from C 1-6 alkyl, C 1-6 alkoxy, halogen, \u2014CN, \u2014CF 3 , \u2014CO 2 R 2 , \u2014CO 2 NHR 3 , \u2014NR 4 R 5 , \u2014NO 2  and \u2014SF 5 , R 2  to R 5  are each independently selected from hydrogen and C 1-6 alkyl, or a salt thereof.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 99.0
- Lexical Diversity: 1.53571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13633230', '13633348', '13633320', '16073355', '12768775']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8150361560890986
- 35 USC 102 Novelty (BERT): 0.583222802086587
- Combined Prediction Score: 0.7918548206888475
- Mean Citation Score: 456.76396000000005
- Max Citation Score: 497.2675
- Similarity Product: 393.8880529421568

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test